Table 4.
Groups | Cases (n) | PAR-2 (n) | PAR-2 positive rate (%) | |||
---|---|---|---|---|---|---|
Negative (-) | Weakly positive (+) | Moderately positive (++) | Strongly positive (+++) | |||
NGM | 59 | 46 | 6 | 5 | 2 | 22.03 |
GWDAC | 8 | 2 | 1 | 3 | 2 | 75.00* |
GMDAC | 29 | 3 | 4 | 5 | 17 | 89.66* |
GPDAC | 104 | 6 | 13 | 27 | 58 | 94.23* |
LMGAC | 53 | 3 | 4 | 12 | 34 | 94.34* |
NGM, normal gastric mucosa; GWDAC, well-differentiated gastric adenocarcinoma; GMDAC, moderately differentiated gastric adenocarcinoma; GPDAC, poorly differentiated gastric adenocarcinoma; LMGAC, lymph node metastasis adenocarcinoma. *Compared with normal gastric mucosa, P=0.0418.